Abstract
Erythrocytes, bone marrow-derived lymphocytes, monocytes, and granulocytes were shown to have a receptor activity for C4. Theis C4 receptor activity was studied in relation to the previously identified C3b and C3d receptors. By assay for inhibition of rosette formation by fluid-phase complement (C), only two different lymphocyte C receptors were demonstrated. The immune adherence receptor, the only one of the two shared in common with erythrocytes, was specific for C4 or the C3c region of C3b, but was unreactive with C3d. The other lymphocyte receptor, the C3d receptor, was specific for C3d fragments, but would also react to a lesser extent with the C3d region of uncleaved C3b. ThC3d receptor did not react with either C3c or C4. This specificity of the C3d receptor allowed certain cells which contained only C3d receptors to form rosettes with EAC1-3b and EAC1-3d, but not with EAC14. However, because C3d receptors bound EAC1-3d or C3d fragments more firmly than they did EAC1-3b or C3b fragments, many other types of cells containing only C3d receptors, formed rosettes with EAC1-3d but not with EAC1-3b. Erythrocytes and those lymphocytes which contained only immune adherence receptors, formed rosettes with EAC14 and EAC1-3D but not with EAC1-3d. A double-label assay was devised for the simultaneous detection of both types of C receptors on individual lymphocytes. This assay involved fluorescence labeling of one of the two C receptors with soluble C fragments in combination with the usual rosette method for labeling the other type of C receptor. With this double-label assay, it was observed that the two different lymphocyte C receptors capped independently and thus were located on different molecules which could each move through the fluid membrane matrix independently of the other.
MeSH Terms
Animals
Antilymphocyte Serum
B-Lymphocytes/immunology
Binding Sites
Calcium
Cell Line
Complement System Proteins
Erythrocytes/immunology
Fluorescent Antibody Technique
Granulocytes/immunology
Humans
Immune Sera
Immunoglobulin M
Immunoglobulins
Leukemia, Lymphoid/immunology
Lymphoid Tissue
Monocytes/immunology
Palatine Tonsil/cytology,immunology
Phagocytosis
Protein Binding
Sheep/immunology
Waldenstrom Macroglobulinemia/immunology
Chemicals
Antilymphocyte Serum
Immune Sera
Immunoglobulin M
Immunoglobulins
Complement System Proteins
Calcium
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Ross G D
Polley M J
References (25)
25 references, click to expand
-
Isolation of a fragment (C3a) of the third component of human complement containing anaphylatoxin and chemotactic activity and description of an anaphylatoxin inactivator of human serum.
J Exp Med. 1969 May 1;129(5):1109-30
PMID: 5778786
-
The second component of human complement: its isolation, fragmentation by C'1 esterase, and incorporation into C'3 convertase.
J Exp Med. 1968 Sep 1;128(3):533-51
PMID: 5666963
-
Complement dependent immune phagocytosis. I. Requirements for C'1, C'4, C'2, C'3.
Exp Cell Res. 1968 Jul;51(1):45-67
PMID: 5661952
-
The demonstration in human serum of "conglutinogen-activating factor" and its effect on the third component of complement.
J Immunol. 1968 Apr;100(4):691-8
PMID: 5645214
-
Physico-chemical characteristics of the third and fourth component of complement after dissociation from complement-cell complexes.
Immunology. 1967 Sep;13(3):293-305
PMID: 6054730
-
Hemolytic activity of lipoprotein-depleted serum and the effect of certain anions on complement.
J Immunol. 1966 Nov;97(5):680-5
PMID: 5926456
-
A STUDY OF MALIGNANT TUMOURS IN NIGERIA BY SHORT-TERM TISSUE CULTURE.
J Clin Pathol. 1965 May;18:261-73
PMID: 14304234
-
ISOLATION OF BETA IF-GLOBULIN FROM HUMAN SERUM AND ITS CHARACTERIZATION AS THE FIFTH COMPONENT OF COMPLEMENT.
J Exp Med. 1965 Aug 1;122:277-98
PMID: 14316946
-
COMPONENTS OF GUINEA PIG COMPLEMENT. I. SEPARATION OF A SERUM FRACTION ESSENTIAL FOR IMMUNE HEMOLYSIS AND IMMUNE ADHERENCE.
J Exp Med. 1963 Nov 1;118:767-93
PMID: 14087621
-
ISOLATION AND DESCRIPTION OF THE FOURTH COMPONENT OF HUMAN COMPLEMENT.
J Exp Med. 1963 Sep 1;118:447-66
PMID: 14078003
-
C3b inactivator of man. II. Fragments produced by C3b inactivator cleavage of cell-bound or fluid phase C3b.
J Immunol. 1971 Sep;107(3):742-50
PMID: 4999095
-
Binding of soluble immune complexes to human lymphoblastoid cells. I. Characterization of receptors for IgG Fc and complement and description of the binding mechanism.
J Exp Med. 1974 Oct 1;140(4):877-94
PMID: 4139225
-
Conglutinin and immunoconglutinins.
Adv Immunol. 1967;6:479-527
PMID: 4860249
-
Receptor for soluble C3 and C3b on human lymphoblastoid (RAJI) cells. Properties and biologocal significance.
J Exp Med. 1974 Mar 1;139(3):696-711
PMID: 4591176
-
Cultured lymphoid cell lines from normal subjects: membrane associated immunoglobulins studied by the mixed antiglobulin reaction.
Cell Immunol. 1972 Nov;5(3):446-58
PMID: 4118947
-
A population of lymphocytes bearing a membrane receptor for antigen-antibody-complement complexes. I. Separation and characterization.
J Exp Med. 1970 Oct 1;132(4):702-20
PMID: 4101362
-
Receptor sites of human monocytes for IgG.
Int Arch Allergy Appl Immunol. 1968;34(1):18-31
PMID: 4174441
-
Enhanced binding of neuraminidase-treated sheep erythrocytes to human T lymphocytes.
Blood. 1973 Dec;42(6):939-46
PMID: 4357270
-
C3b inactivator of man. 3. Further purification and production of antibody to C3b INA.
J Immunol. 1972 Mar;108(3):657-64
PMID: 4622188
-
Combined studies of complement receptor and surface immunoglobulin-bearing cells and sheep erythrocyte rosette-forming cells in normal and leukemic human lymphocytes.
J Clin Invest. 1973 Feb;52(2):377-85
PMID: 4567307
-
Rosette-forming human lymphoid cell lines. I. Establishment and evidence for origin of thymus-derived lymphocytes.
J Natl Cancer Inst. 1972 Sep;49(3):891-5
PMID: 4567231
-
Two different complement receptors on human lymphocytes. One specific for C3b and one specific for C3b inactivator-cleaved C3b.
J Exp Med. 1973 Oct 1;138(4):798-811
PMID: 4542735
-
Receptor for the fourth component of complement on human B lymphocytes and cultured human lymphoblastoid cells.
J Exp Med. 1974 Nov 1;140(5):1336-47
PMID: 4547573
-
Enharncement of the hemolytic activity of the second component of human complement by oxidation.
J Exp Med. 1967 Dec 1;126(6):1013-25
PMID: 4964564
-
Immune adherence by the fourth component of complement.
Science. 1969 Jul 25;165(3891):396-8
PMID: 5815256